Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Europe Radiotherapy Market - Industry Trends and Forecast To 2027

Published by Data Bridge Market Research Private Limited Product code 961961
Published Content info 140 Pages
Delivery time: 1-2 business days
Price
Back to Top
Europe Radiotherapy Market - Industry Trends and Forecast To 2027
Published: August 1, 2020 Content info: 140 Pages
Description

Europe radiotherapy market is projected to register a CAGR of 5.1% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:

Europe Radiotherapy Market, By Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/Radiopharmaceuticals & Others), Product (External Beam Radiotherapy, Internal Radiotherapy Products, Radiotherapy Software & Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer & Others), End User (Hospitals, Radiation Therapy Centers, Specialty Clinics & Others), Distribution Channel (Direct Tender, Retail Sales & Others), Country (Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey Ukraine & Rest of Europe) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the Europe radiotherapy market are:

Increasing technology advancement in radiotherapy products

Increasing cancer treatment procedure

Market Players:

The key market players for Europe radiotherapy market are listed below:

Varian Medical Systems, Inc.

Mevion Medical Systems

VIEWRAY TECHNOLOGIES, INC. (a subsidiary of VIEWRAY)

Siemens Healthcare GmbH

Elekta AB, Accuray Incorporated

IBA Worldwide

Eckert & Ziegler BEBIG

RaySearch Laboratories

Brainlab AG

Koninklijke Philips N.V.

GE Healthcare, Hitachi, Ltd.

Advanced Accelerator Applications (A Subsidiary of Novartis AG)

Nordion (Canada) Inc.

Sumitomo Heavy Industries, Ltd.

Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF EUROPE RADIOTHERAPY MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 TYPE LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 MARKET APPLICATION COVERAGE GRID
  • 2.11 VENDOR SHARE ANALYSIS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 EUROPE RADIOTHERAPY MARKET, MARKET SHARE ANALYSIS
    • 4.1.1 MARKET SHARE ANALYSIS: EUROPE
    • 4.1.2 MARKET SHARE ANALYSIS: NORTH AMERICA
      • 4.1.2.1 MARKET SHARE ANALYSIS: U.S.
      • 4.1.2.2 MARKET SHARE ANALYSIS: CANADA
      • 4.1.2.3 MARKET SHARE ANALYSIS: MEXICO
    • 4.1.3 MARKET SHARE ANALYSIS: EUROPE
      • 4.1.3.1 MARKET SHARE ANALYSIS: GERMANY
      • 4.1.3.2 MARKET SHARE ANALYSIS: FRANCE
      • 4.1.3.3 MARKET SHARE ANALYSIS: ITALY
      • 4.1.3.4 MARKET SHARE ANALYSIS: U.K.
      • 4.1.3.5 MARKET SHARE ANALYSIS: SPAIN
      • 4.1.3.6 MARKET SHARE ANALYSIS: RUSSIA
      • 4.1.3.7 MARKET SHARE ANALYSIS: NETHERLANDS
      • 4.1.3.8 MARKET SHARE ANALYSIS: SWITZERLAND
      • 4.1.3.9 MARKET SHARE ANALYSIS: BELGIUM
      • 4.1.3.10 MARKET SHARE ANALYSIS: TURKEY
      • 4.1.3.11 MARKET SHARE ANALYSIS: UKRAINE
    • 4.1.4 MARKET SHARE ANALYSIS: ASIA-PACIFIC
      • 4.1.4.1 MARKET SHARE ANALYSIS: CHINA
      • 4.1.4.2 MARKET SHARE ANALYSIS: JAPAN
      • 4.1.4.3 MARKET SHARE ANALYSIS: INDIA
      • 4.1.4.4 MARKET SHARE ANALYSIS: AUSTRALIA
      • 4.1.4.5 MARKET SHARE ANALYSIS: SOUTH KOREA
      • 4.1.4.6 MARKET SHARE ANALYSIS: INDONESIA
      • 4.1.4.7 MARKET SHARE ANALYSIS: THAILAND
      • 4.1.4.8 MARKET SHARE ANALYSIS: SINGAPORE
      • 4.1.4.9 MARKET SHARE ANALYSIS: MALAYSIA
      • 4.1.4.10 MARKET SHARE ANALYSIS: PHILIPPINES
    • 4.1.5 MARKET SHARE ANALYSIS: SOUTH AMERICA
      • 4.1.5.1 MARKET SHARE ANALYSIS: BRAZIL
      • 4.1.5.2 MARKET SHARE ANALYSIS: ARGENTINA
      • 4.1.5.3 MARKET SHARE ANALYSIS: CHILE
    • 4.1.6 MARKET SHARE ANALYSIS: MIDDLE EAST AND AFRICA
      • 4.1.6.1 MARKET SHARE ANALYSIS: SOUTH AFRICA
      • 4.1.6.2 MARKET SHARE ANALYSIS: SAUDI ARABIA
      • 4.1.6.3 MARKET SHARE ANALYSIS: UAE
      • 4.1.6.4 MARKET SHARE ANALYSIS: EGYPT
      • 4.1.6.5 MARKET SHARE ANALYSIS: ISRAEL
  • 4.2 EUROPE PROTON BEAM THERAPY IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.2.1 COMPANY SHARE ANALYSIS: EUROPE
    • 4.2.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.2.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.2.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.2.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.2.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.2.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.2.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.2.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.2.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.2.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.2.4.1 company share analysis: CHINA
      • 4.2.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.2.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.2.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA
  • 4.3 EUROPE BRACHYTHERAPY IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.3.1 COMPANY SHARE ANALYSIS: EUROPE
    • 4.3.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.3.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.3.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.3.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.3.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.3.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.3.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.3.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.3.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.3.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.3.4.1 COMPANY SHARE ANALYSIS: CHINA
      • 4.3.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.3.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.3.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA
  • 4.4 EUROPE IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.4.1 COMPANY SHARE ANALYSIS: EUROPE
    • 4.4.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.4.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.4.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.4.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.4.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.4.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.4.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.4.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.4.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.4.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.4.4.1 COMPANY SHARE ANALYSIS: CHINA
      • 4.4.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.4.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.4.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA
  • 4.5 EUROPE STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.5.1 COMPANY SHARE ANALYSIS: EUROPE
    • 4.5.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.5.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.5.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.5.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.5.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.5.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.5.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.5.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.5.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.5.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.5.4.1 COMPANY SHARE ANALYSIS: CHINA
      • 4.5.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.5.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.5.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA

5 IMPACT OF COVID-19 ON EUROPE RADIOTHERAPY MARKET

  • 5.1 IMPACT ANALYSIS ON DEMAND
  • 5.2 CONCLUSION

6 MARKET OVERVIEW

  • 6.1 DRIVERS
    • 6.1.1 GROWING PREVALENCE OF CANCER DISEASE
    • 6.1.2 NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMENT
    • 6.1.3 INCREASING ADOPTION OF RADIOTHERAPY DEVICES AND PROCEDURES
    • 6.1.4 RISING PREFERENCE FOR NON-SURGICAL PROCEDURES
  • 6.2 RESTRAINTS
    • 6.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
    • 6.2.2 COMPLEX NATURE OF RADIOTHERAPY
    • 6.2.3 HIGH COST OF RADIOTHERAPY PROCEDURES
  • 6.3 OPPORTUNITIES
    • 6.3.1 INCREASING HEALTHCARE EXPENDITURES FOR CANCER TREATMENTS
    • 6.3.2 GROWING GOVERNMENT INITIATIVES TOWARDS CANCER TREATMENT
    • 6.3.3 RISING PATIENTS AWARENESS TOWARDS CANCER TREATMENT
  • 6.4 CHALLENGES
    • 6.4.1 STRICT REGULATIONS AND STANDARDS FOR THE APPROVAL AND COMMERCIALIZATION OF RADIOTHERAPY PRODUCTS
    • 6.4.2 RISK OF RADIATION EXPOSURE

7 EUROPE RADIOTHERAPY MARKET, BY TYPE

  • 7.1 OVERVIEW
  • 7.2 EXTERNAL-BEAM RADIATION THERAPY
    • 7.2.1 IMAGE-GUIDED RADIATION THERAPY (IGRT)
    • 7.2.2 PROTON BEAM THERAPY
    • 7.2.3 STEREOTACTIC RADIATION THERAPY
    • 7.2.4 INTENSITY MODULATED RADIATION THERAPY (IMRT)
    • 7.2.5 THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY (3D-CRT)
    • 7.2.6 VOLUMETRIC MODULATED ARC THERAPY (VMAT)
    • 7.2.7 OTHERS
  • 7.3 INTERNAL RADIATION THERAPY
    • 7.3.1 BRACHYTHERAPY
    • 7.3.2 SELECTIVE INTERNAL RADIATION THERAPY (SIRT)
    • 7.3.3 BRACHYTHERAPY
      • 7.3.3.1 HIGH DOSE BRACHYTHERAPY
      • 7.3.3.2 LOW DOSE BRACHYTHERAPY
  • 7.4 SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS
  • 7.5 OTHERS

8 EUROPE RADIOTHERAPY MARKET, BY PRODUCT

  • 8.1 OVERVIEW
  • 8.2 EXTERNAL BEAM RADIOTHERAPY
    • 8.2.1 LINAC
    • 8.2.2 PROTON THERAPY
    • 8.2.3 CYBER KNIFE
    • 8.2.4 GAMMA KNIFE
    • 8.2.5 OTHERS
  • 8.3 INTERNAL RADIOTHERAPY PRODUCTS
    • 8.3.1 SEEDS
    • 8.3.2 AFTERLOADERS
    • 8.3.3 OTHERS
  • 8.4 RADIOTHERAPY SOFTWARE
    • 8.4.1 IMAGE GUIDING SOFTWARE
    • 8.4.2 TREATMENT PLANNING SOFTWARE
    • 8.4.3 PATIENT POSITIONING SOFTWARE
    • 8.4.4 DOSAGE PLANNING SOFTWARE
    • 8.4.5 OTHERS

9 EUROPE RADIOTHERAPY MARKET, BY APPLICATION

  • 9.1 OVERVIEW
  • 9.2 BREAST CANCER
  • 9.3 LUNG CANCER
  • 9.4 PROSTATE CANCER
  • 9.5 COLORECTAL CANCER
  • 9.6 LYMPHOMA
  • 9.7 LIVER CANCER
  • 9.8 THYROID CANCER
  • 9.9 BRAIN CANCER
  • 9.10 CERVICAL CANCER
  • 9.11 SPINE CANCER
  • 9.12 OTHERS

10 EUROPE RADIOTHERAPY MARKET, BY END USER

  • 10.1 OVERVIEW
  • 10.2 HOSPITALS
  • 10.3 RADIATION THERAPY CENTERS
  • 10.4 SPECIALTY CLINICS
  • 10.5 OTHERS

11 EUROPE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL

  • 11.1 OVERVIEW
  • 11.2 DIRECT TENDER
  • 11.3 RETAIL SALES
  • 11.4 OTHERS

12 EUROPE RADIOTHERAPY MARKET, BY GEOGRAPHY

  • 12.1 EUROPE
    • 12.1.1 GERMANY
    • 12.1.2 FRANCE
    • 12.1.3 ITALY
    • 12.1.4 U.K.
    • 12.1.5 SPAIN
    • 12.1.6 RUSSIA
    • 12.1.7 NETHERLANDS
    • 12.1.8 SWITZERLAND
    • 12.1.9 BELGIUM
    • 12.1.10 TURKEY
    • 12.1.11 UKRAINE
    • 12.1.12 REST OF EUROPE

13 EUROPE RADIOTHERAPY MARKET, COMPANY LANDSCAPE

  • 13.1 COMPANY SHARE ANALYSIS: EUROPE

14 SWOT ANALYSIS

15 COMPANY PROFILE

  • 15.1 VARIAN MEDICAL SYSTEMS, INC.
    • 15.1.1 COMPANY SNAPSHOT
    • 15.1.2 REVENUE ANALYSIS
    • 15.1.3 COMPANY SHARE ANALYSIS
    • 15.1.4 PRODUCT PORTFOLIO
    • 15.1.5 RECENT DEVELOPMENTS
  • 15.2 ELEKTA AB
    • 15.2.1 COMPANY SNAPSHOT
    • 15.2.2 REVENUE ANALYSIS
    • 15.2.3 COMPANY SHARE ANALYSIS
    • 15.2.4 PRODUCT PORTFOLIO
    • 15.2.5 RECENT DEVELOPMENTS
  • 15.3 SIEMENS HEALTHCARE GMBH
    • 15.3.1 COMPANY SNAPSHOT
    • 15.3.2 REVENUE ANALYSIS
    • 15.3.3 COMPANY SHARE ANALYSIS
    • 15.3.4 PRODUCT PORTFOLIO
    • 15.3.5 RECENT DEVELOPMENTS
  • 15.4 GE HEALTHCARE
    • 15.4.1 COMPANY SNAPSHOT
    • 15.4.2 REVENUE ANALYSIS
    • 15.4.3 COMPANY SHARE ANALYSIS
    • 15.4.4 PRODUCT PORTFOLIO
    • 15.4.5 RECENT DEVELOPMENT
  • 15.5 ACCURAY INCORPORATED
    • 15.5.1 COMPANY SNAPSHOT
    • 15.5.2 REVENUE ANALYSIS
    • 15.5.3 COMPANY SHARE ANALYSIS
    • 15.5.4 PRODUCT PORTFOLIO
    • 15.5.5 RECENT DEVELOPMENT
  • 15.6 KONINKLIJKE PHILIPS N.V.
    • 15.6.1 COMPANY SNAPSHOT
    • 15.6.2 REVENUE ANALYSIS
    • 15.6.3 PRODUCT PORTFOLIO
    • 15.6.4 RECENT DEVELOPMENTS
  • 15.7 ADVANCED ACCELERATOR APPLICATIONS (A SUBSIDIARY OF NOVARTIS AG)
    • 15.7.1 COMPANY SNAPSHOT
    • 15.7.2 REVENUE ANALYSIS
    • 15.7.3 PRODUCT PORTFOLIO
    • 15.7.4 RECENT DEVELOPMENT
  • 15.8 BRAINLAB AG
    • 15.8.1 COMPANY SNAPSHOT
    • 15.8.2 PRODUCT PORTFOLIO
    • 15.8.3 RECENT DEVELOPMENT
  • 15.9 CIVCO RADIOTHERAPY (A SUBSIDIARY OF ROPER TECHNOLOGIES, INC.)
    • 15.9.1 COMPANY SNAPSHOT
    • 15.9.2 REVENUE ANALYSIS
    • 15.9.3 PRODUCT PORTFOLIO
    • 15.9.4 RECENT DEVELOPMENT
  • 15.10 ECKERT & ZIEGLER BEBIG
    • 15.10.1 COMPANY SNAPSHOT
    • 15.10.2 REVENUE ANALYSIS
    • 15.10.3 PRODUCT PORTFOLIO
    • 15.10.4 RECENT DEVELOPMENT
  • 15.11 HITACHI, LTD.
    • 15.11.1 COMPANY SNAPSHOT
    • 15.11.2 REVENUE ANALYSIS
    • 15.11.3 PRODUCT PORTFOLIO
    • 15.11.4 RECENT DEVELOPMENT
  • 15.12 IBA WORLDWIDE
    • 15.12.1 COMPANY SNAPSHOT
    • 15.12.2 REVENUE ANALYSIS
    • 15.12.3 PRODUCT PORTFOLIO
    • 15.12.4 RECENT DEVELOPMENT
  • 15.13 ISORAY INC.
    • 15.13.1 COMPANY SNAPSHOT
    • 15.13.2 REVENUE ANALYSIS
    • 15.13.3 PRODUCT PORTFOLIO
    • 15.13.4 RECENT DEVELOPMENT
  • 15.14 MEVION MEDICAL SYSTEMS
    • 15.14.1 COMPANY SNAPSHOT
    • 15.14.2 PRODUCT PORTFOLIO
    • 15.14.3 RECENT DEVELOPMENT
  • 15.15 NORDION (CANADA) INC.
    • 15.15.1 COMPANY SNAPSHOT
    • 15.15.2 PRODUCT PORTFOLIO
    • 15.15.3 RECENT DEVELOPMENT
  • 15.16 PROTOM INTERNATIONAL
    • 15.16.1 COMPANY SNAPSHOT
    • 15.16.2 PRODUCT PORTFOLIO
    • 15.16.3 RECENT DEVELOPMENT
  • 15.17 PROVISION HEALTHCARE
    • 15.17.1 COMPANY SNAPSHOT
    • 15.17.2 SOLUTION PORTFOLIO
    • 15.17.3 RECENT DEVELOPMENT
  • 15.18 RAYSEARCH LABORATORIES
    • 15.18.1 COMPANY SNAPSHOT
    • 15.18.2 REVENUE ANALYSIS
    • 15.18.3 PRODUCT PORTFOLIO
    • 15.18.4 RECENT DEVELOPMENT
  • 15.19 SUMITOMO HEAVY INDUSTRIES, LTD.
    • 15.19.1 COMPANY SNAPSHOT
    • 15.19.2 REVENUE ANALYSIS
    • 15.19.3 PRODUCT PORTFOLIO
    • 15.19.4 RECENT DEVELOPMENT
  • 15.20 VIEWRAY TECHNOLOGIES, INC. (A SUBSIDIARY OF VIEWRAY)
    • 15.20.1 COMPANY SNAPSHOT
    • 15.20.2 REVENUE ANALYSIS
    • 15.20.3 PRODUCT PORTFOLIO
    • 15.20.4 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 EUROPE CANCER INCIDENCE (2018)
  • TABLE 2 EUROPE CANCER INCIDENCE (2018)
  • TABLE 3 EUROPE CANCER INCIDENCE (2018)
  • TABLE 4 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC
  • TABLE 5 PRODUCT CLASSIFICATION
  • TABLE 6 EUROPE RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 7 EUROPE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 8 EUROPE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 9 EUROPE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 10 EUROPE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 11 EUROPE BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 12 EUROPE SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 13 EUROPE OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 14 EUROPE RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 15 EUROPE RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 16 EUROPE DEVICES IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 17 EUROPE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 18 EUROPE INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 19 EUROPE INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 20 EUROPE RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 21 EUROPE RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 22 EUROPE RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 23 EUROPE BREAST CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 24 EUROPE LUNG CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 25 EUROPE PROSTATE CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 26 EUROPE COLORECTAL CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 27 EUROPE LYMPHOMA IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 28 EUROPE LIVER CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 29 EUROPE THYROID CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 30 EUROPE BRAIN CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 31 EUROPE CERVICAL CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 32 EUROPE SPINE CANCER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 33 EUROPE OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 34 EUROPE RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 35 EUROPE HOSPITALS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 36 EUROPE RADIATION THERAPY CENTERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 37 EUROPE SPECIALTY CLINICS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 38 EUROPE OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 39 EUROPE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 40 EUROPE DIRECT TENDER IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 41 EUROPE RETAIL SALES IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 42 EUROPE OTHERS IN RADIOTHERAPY MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 43 EUROPE RADIOTHERAPY MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 44 EUROPE RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 45 EUROPE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 46 EUROPE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 47 EUROPE BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 48 EUROPE RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 49 EUROPE RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 50 EUROPE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 51 EUROPE INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 52 EUROPE RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 53 EUROPE RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 54 EUROPE RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 55 EUROPE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 56 GERMANY RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 57 GERMANY EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 58 GERMANY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 59 GERMANY BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 60 GERMANY RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 61 GERMANY RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 62 GERMANY EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 63 GERMANY INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 64 GERMANY RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 65 GERMANY RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 66 GERMANY RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 67 GERMANY RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 68 FRANCE RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 69 FRANCE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 70 FRANCE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 71 FRANCE BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 72 FRANCE RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 73 FRANCE RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 74 FRANCE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 75 FRANCE INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 76 FRANCE RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 77 FRANCE RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 78 FRANCE RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 79 FRANCE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 80 ITALY RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 81 ITALY EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 82 ITALY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 83 ITALY BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 84 ITALY RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 85 ITALY RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 86 ITALY EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 87 ITALY INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 88 ITALY RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 89 ITALY RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 90 ITALY RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 91 ITALY RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 92 U.K. RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 93 U.K. EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 94 U.K. INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 95 U.K. BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 96 U.K. RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 97 U.K. RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 98 U.K. EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 99 U.K. INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 100 U.K. RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 101 U.K. RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 102 U.K. RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 103 U.K. RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 104 SPAIN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 105 SPAIN EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 106 SPAIN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 107 SPAIN BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 108 SPAIN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 109 SPAIN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 110 SPAIN EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 111 SPAIN INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 112 SPAIN RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 113 SPAIN RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 114 SPAIN RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 115 SPAIN RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 116 RUSSIA RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 117 RUSSIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 118 RUSSIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 119 RUSSIA BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 120 RUSSIA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 121 RUSSIA RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 122 RUSSIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 123 RUSSIA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 124 RUSSIA RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 125 RUSSIA RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 126 RUSSIA RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 127 RUSSIA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 128 NETHERLANDS RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 129 NETHERLANDS EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 130 NETHERLANDS INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 131 NETHERLANDS BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 132 NETHERLANDS RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 133 NETHERLANDS RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 134 NETHERLANDS EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 135 NETHERLANDS INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 136 NETHERLANDS RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 137 NETHERLANDS RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 138 NETHERLANDS RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 139 NETHERLANDS RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 140 SWITZERLAND RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 141 SWITZERLAND EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 142 SWITZERLAND INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 143 SWITZERLAND BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 144 SWITZERLAND RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 145 SWITZERLAND RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 146 SWITZERLAND EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 147 SWITZERLAND INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 148 SWITZERLAND RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 149 SWITZERLAND RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 150 SWITZERLAND RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 151 SWITZERLAND RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 152 BELGIUM RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 153 BELGIUM EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 154 BELGIUM INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 155 BELGIUM BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 156 BELGIUM RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 157 BELGIUM RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 158 BELGIUM EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 159 BELGIUM INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 160 BELGIUM RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 161 BELGIUM RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 162 BELGIUM RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 163 BELGIUM RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 164 TURKEY RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 165 TURKEY EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 166 TURKEY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 167 TURKEY BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 168 TURKEY RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 169 TURKEY RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 170 TURKEY EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 171 TURKEY INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 172 TURKEY RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 173 TURKEY RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 174 TURKEY RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 175 TURKEY RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 176 UKRAINE RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 177 UKRAINE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 178 UKRAINE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 179 UKRAINE BRACHYTHERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 180 UKRAINE RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 181 UKRAINE RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (UNITS)
  • TABLE 182 UKRAINE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 183 UKRAINE INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 184 UKRAINE RADIOTHERAPY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT, 2018-2027 (USD MILLION)
  • TABLE 185 UKRAINE RADIOTHERAPY MARKET, BY APPLICATION, 2018-2027 (USD MILLION)
  • TABLE 186 UKRAINE RADIOTHERAPY MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 187 UKRAINE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 188 REST OF EUROPE RADIOTHERAPY MARKET, BY TYPE, 2018-2027 (USD MILLION)
Back to Top